SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-067694
Filing Date
2017-03-02
Accepted
2017-03-02 16:21:05
Documents
3
Period of Report
2017-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d339390d8k.htm 8-K 16061
2 EX-99.1 d339390dex991.htm EX-99.1 54620
3 GRAPHIC g339390g0302090111246.jpg GRAPHIC 2490
  Complete submission text file 0001193125-17-067694.txt   75379
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 17659082
SIC: 2834 Pharmaceutical Preparations